Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
European Heart Journal|January 18, 2006
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protectionMichael Jonas, Gregg W Stone, Roxana Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 26, 2018
SCAI 2018 Think Tank Proceedings: "What should the role of the surgeon be in TAVR, both as a co-operator and in-patient evaluation for TAVR?Jay S Giri, Molly Szerlip, Chandan Devireddy, et al.
The American Journal of Cardiology|April 18, 2007
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)Eugenia Nikolsky, Cindy L Grines, David A Cox, et al.
Diabetes, Obesity & Metabolism|June 30, 2021
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11Enzo Bonora, Juan P Frias, Francisco J Tinahones, et al.
International Journal of Biometeorology|January 5, 2020
Cohort antler size signals environmental stress in a moderate climateBronson K Strickland, P Grady Dixon, Phillip D Jones, et al.
Journal of Interventional Cardiology|August 3, 2006
Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?Kishore J Harjai, Rajendra H Mehta, Gregg W Stone, et al.
The American Journal of Cardiology|February 5, 2004
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial)Amir Halkin, Eve Aymong, David A Cox, et al.
American Heart Journal|June 3, 2008
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)George Dangas, Gregg W Stone, Mitchell D Weinberg, et al.
The American Journal of Cardiology|October 1, 2003
Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic-related group systemBeth A Bartholomew, Kishore J Harjai, Cindy L Grines, et al.
The American Journal of Cardiology|May 15, 2003
One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplastyThanh T Nguyen, William W O'Neill, Cindy L Grines, et al.
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
European Heart Journal|January 18, 2006
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protectionMichael Jonas, Gregg W Stone, Roxana Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 26, 2018
SCAI 2018 Think Tank Proceedings: "What should the role of the surgeon be in TAVR, both as a co-operator and in-patient evaluation for TAVR?Jay S Giri, Molly Szerlip, Chandan Devireddy, et al.
The American Journal of Cardiology|April 18, 2007
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)Eugenia Nikolsky, Cindy L Grines, David A Cox, et al.
Diabetes, Obesity & Metabolism|June 30, 2021
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11Enzo Bonora, Juan P Frias, Francisco J Tinahones, et al.
International Journal of Biometeorology|January 5, 2020
Cohort antler size signals environmental stress in a moderate climateBronson K Strickland, P Grady Dixon, Phillip D Jones, et al.
Journal of Interventional Cardiology|August 3, 2006
Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?Kishore J Harjai, Rajendra H Mehta, Gregg W Stone, et al.
The American Journal of Cardiology|February 5, 2004
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial)Amir Halkin, Eve Aymong, David A Cox, et al.
American Heart Journal|June 3, 2008
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)George Dangas, Gregg W Stone, Mitchell D Weinberg, et al.
The American Journal of Cardiology|October 1, 2003
Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic-related group systemBeth A Bartholomew, Kishore J Harjai, Cindy L Grines, et al.
The American Journal of Cardiology|May 15, 2003
One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplastyThanh T Nguyen, William W O'Neill, Cindy L Grines, et al.
Pageof 17